Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.

This publication has 13 references indexed in Scilit:

• Relationships between DNA Incorporation, Mutant Frequency, and Loss of Heterozygosity at the TK Locus in Human Lymphoblastoid Cells Exposed to 3'-Azido-3'-deoxythymidine
  Toxicological Sciences, 2000
• Multiorgan Transplacental and Neonatal Carcinogenicity of 3′-Azido-3′-deoxythymidine in Mice
  Toxicology and Applied Pharmacology, 1999
• Genotoxicity of 3′-azido-3′-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1999
• Nonclinical Toxicology Studies with Zidovudine: Genetic Toxicity Tests and Carcinogenicity Bioassays in Mice and Rats
  Fundamental and Applied Toxicology, 1996
• Induction of micronuclei by low doses of azidothymidine (AZT)
  Mutation Research/Genetic Toxicology, 1996
• Clinical Pharmacokinetics of Zidovudine
  Clinical Pharmacokinetics, 1996
• Metabolism of zidovudine
  General Pharmacology: The Vascular System, 1995
• Pharmacokinetic Optimisation of Antiretroviral Therapy in Patients with HIV Infection
  Clinical Pharmacokinetics, 1995
• Genotoxic activity of azidothymidine (AZT) in in vitro systems
  Mutation Research/Genetic Toxicology, 1994
• Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326
  International Journal of Radiation Oncology*Biology*Physics, 1992